The female stress urinary incontinence treatment device market is projected to be worth US$ 770.0 millionin 2024. The market is anticipated to reach US$ 1,432.0 millionby 2034. The market is further expected to surge at a CAGR of 6.4% during the forecast period 2024 to 2034.

Country-wise Insights

Category-wise Insights

Report Scope

The Urinary Incontinence Treatment Devices Market Report is Segmented by Product (Urethral & Vaginal Slings, Artificial Urinary Sphincters, and More), Incontinence Type (Stress, Urge, Mixed, and More), Device Category (Internal Devices and External Devices), End User (Hospitals, Ambulatory Surgical Centers, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

The urinary incontinence market was valued at USD 12.80 Billion in 2024, driven by the increasing prevalence of urinary incontinence and rising awareness about available treatments across 8 major markets. The market is anticipated to grow at a CAGR of 6.40% during the forecast period of 2025-2034, with the values likely to reach USD 23.80 Billion by 2034.

Key Market Trends and Insights

• Anticholinergic drugs led the treatment category, owing to their widespread use and established efficacy in managing urinary urgency and frequency symptoms.
• Stress incontinence is poised to dominate the segment by incontinence type by holding over 30% of the global share.
• Female patients accounted for the largest market share by gender.

Market Size and Forecast

• Market Size (2024): USD 12.80 Billion
• Projected Market Size (2034): USD 23.80 Billion
• CAGR (2025-2034): 6.40%

The global urinary incontinence devices market size reached USD 3.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.2 Billion by 2033, exhibiting a growth rate (CAGR) of 8.88% during 2025-2033. The growing occurrence of neurological diseases, diabetes, and obesity; increasing number of individuals who are addicted to smoking and alcohol consumption, and rising preference of patients to opt for minimally invasive (MI) treatment options represent some of the key factors driving the market.

IMARC Group provides an analysis of the key trends in each sub-segment of the global urinary incontinence devices market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product, category, incontinence type, patient and end user.

Snapshot img

Urinary Incontinence Devices Market Size 2024-2028

The urinary incontinence devices market size is forecast to increase by USD 1.73 billion, at a CAGR of 10.4% between 2023 and 2028.

The market is driven by the increasing prevalence of physical and medical conditions leading to urinary incontinence. With an aging population and rising incidences of chronic diseases, the demand for specialized urology care is on the rise. However, market growth faces challenges due to product recalls. These incidents can significantly impact market trust and consumer confidence, necessitating stricter regulatory oversight and quality control measures.
Companies seeking to capitalize on market opportunities must prioritize product safety and reliability, while also addressing the unmet needs of an aging population and those with chronic conditions. Effective collaboration with healthcare providers and patient advocacy groups can also help build trust and drive market growth.

What will be the Size of the Urinary Incontinence Devices Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample

The market continues to evolve, driven by advancements in technology and the growing demand for effective solutions to manage this condition. This dynamic market encompasses a range of products and technologies, including post-surgical care devices, electronic monitoring systems, medical adhesives, drug delivery systems, and leakage detection systems. Continence product materials, such as superabsorbent polymers and biocompatible materials, play a crucial role in ensuring tissue compatibility and patient comfort. Surgically placed devices, like surgical implants and bladder training devices, offer long-term solutions for those with severe incontinence. External catheters, wearable sensors, and disposable undergarments provide discreet and convenient options for managing leakage.

Moreover, the integration of advanced technologies, such as pressure sensors, pH indicators, wireless monitoring, and neuro stimulation therapy, enhances the effectiveness of these devices. Fluid management systems, absorbent polymers, and moisture wicking fabrics contribute to improving patient comfort and reducing the risk of skin irritation. Continence management strategies, such as pelvic floor exercises and bladder control exercises, complement the use of these devices. Prophylactic treatment and reusable diapers offer cost-effective solutions for those with mild to moderate incontinence. The market's ongoing unfolding reflects the industry's commitment to developing innovative solutions that cater to the diverse needs of patients and healthcare providers.

How is this Urinary Incontinence Devices Industry segmented?

The urinary incontinence devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Urinary slings
  Neuromodulation devices
  Urinary catheters


Geography

  North America

    US
    Canada


  Europe

    Germany
    UK


  APAC

    China


  Rest of World (ROW)

By Product Insights

The urinary slings segment is estimated to witness significant growth during the forecast period.

In the realm of post-surgical care, the market for urinary incontinence devices continues to evolve, with a focus on advanced technologies and solutions. Companies are developing a range of devices to address various types of incontinence, from stress incontinence urinary slings made with mesh or human tissue, to surgically placed devices that offer leakage management and continence management strategies. These solutions include electronic monitoring systems, medical adhesives, drug delivery systems, and leakage detection systems, all designed to enhance patient comfort and improve outcomes. Advancements in continence product materials, such as superabsorbent materials and biocompatible fabrics, are enabling the creation of more effective and comfortable disposable undergarments, reusable diapers, and continence pads.

Wearable sensors and wireless monitoring systems are also gaining popularity, offering real-time leakage detection and bladder capacity measurement. To cater to diverse patient needs, companies are exploring various technologies, including pressure sensors, fluid absorption rates, and sensor integration. Neuro stimulation therapy, skin barrier creams, and fluid management systems are also being employed to address the challenges of urinary incontinence. Additionally, prophylactic treatment and pelvic floor exercises are being integrated into continence management strategies to prevent incontinence and improve bladder control. The market for

Urinary incontinence market size is expected to register a CAGR of 7.6% during the forecast period, Growing prevalence of urinary incontinence among geriatric population and women, rapid advancements in urinary incontinence devices, rising incidence of incontinence associated with other medical and physical conditions are key factors

Urinary Incontinence Market Outlook

According to our latest research, the global urinary incontinence market size reached USD 13.4 billion in 2024, reflecting robust demand for innovative treatment solutions and management products worldwide. The market is expected to expand at a CAGR of 7.1% from 2025 to 2033, projecting a value of USD 24.8 billion by 2033. This growth trajectory is primarily driven by the aging global population, rising awareness of urinary incontinence, and continuous advancements in medical devices and pharmaceuticals targeting this condition.

A significant growth factor fueling the urinary incontinence market is the increasing prevalence of chronic diseases and aging-related health issues. As the global population ages, the incidence of urinary incontinence, particularly among women and the elderly, is on the rise. Chronic conditions such as diabetes, obesity, and neurological disorders further exacerbate the risk of developing incontinence. The World Health Organization estimates that by 2030, one in six people in the world will be aged 60 years or over, highlighting the urgent need for effective urinary incontinence management solutions. This demographic trend is a key driver for market expansion, as healthcare systems and manufacturers focus on meeting the unique needs of this growing patient population.

Another pivotal growth factor is the ongoing innovation and technological advancements in the urinary incontinence market. The development of minimally invasive devices, smart wearable sensors, and improved absorbent products is transforming patient care and comfort. Pharmaceutical companies are also investing heavily in the research and development of novel drug formulations that offer better efficacy and fewer side effects. The integration of digital health technologies, such as telemedicine and remote monitoring, is further enhancing patient adherence and outcomes. These innovations not only increase the adoption rate of urinary incontinence products but also improve the quality of life for patients, thereby driving market growth.

Growing awareness and destigmatization of urinary incontinence are also contributing to market expansion. Over the past decade, various public health campaigns and educational initiatives have worked to reduce the social stigma associated with incontinence, encouraging more individuals to seek medical advice and treatment. This shift in perception, coupled with the increasing availability of over-the-counter products and home care solutions, is expanding the potential consumer base. Healthcare providers are also better equipped to diagnose and manage urinary incontinence, leading to more proactive treatment approaches and higher demand for both devices and pharmaceuticals.

From a regional perspective, North America continues to dominate the global urinary incontinence market, accounting for the largest revenue share in 2024. The region’s advanced healthcare infrastructure, high awareness levels, and significant healthcare expenditure contribute to its leading position. Europe follows closely, supported by a well-established healthcare system and a rapidly aging population. The Asia Pacific region is emerging as a high-growth market, driven by improving healthcare access, rising awareness, and increasing investments by both public and private sectors. Latin America and the Middle East & Africa, while representing smaller market shares, are witnessing steady growth due to improving healthcare facilities and increasing recognition of urinary incontinence as a significant health concern.

Product Type Analysis

The urinary incontinence market is segmented by product type into devices, pharmaceuticals, absorbent products, and others. Devices, including catheters, urethral slings, and electrical stimulation devices, have witnessed significant technological advancements in recent years. These innovations focus on enhancing patient comfort, reducing the risk of infection, and improving long-term outcomes. The adoption of minimall

Electrical Stimulation Devices: Stimulate pelvic floor muscles to improve bladder control.Foley Catheters: Used for continuous urine drainage in patients with severe incontinence.Antimicrobial Foley Catheters: Prevent urinary tract infections associated with catheter use.Urethral Bulking Agents: Injected into the urethra to create a bulking effect and reduce urine leakage. Recent developments include: November 2020 BladderCell started a clinical trial for the bioelectric treatment of urine incontinence., May 2020 Two new kinds of prosthetic urinary sphincters from Rigicon have been released the ContiClassic and ContiReflex variants., March 2019 Coloplast Corporation and Premier Inc., a healthcare provider based in the United States, agreed to a three-year purchase agreement for Coloplast's catheter product portfolio. With its integrated supply chain, advising, and data analytics solutions, Premier Inc. has a network alliance of around 4,000 US hospitals that might be used to expand Coloplast's relationships at a cheaper cost.. Notable trends are: Rising investment in research and development of new drugs to propel market growth.

In 2023, the value of the urinary incontinence treatment devices global market reached over three billion U.S. dollars and is forecasted to increase to around 6.5 billion U.S. dollars by 2032. This statistic shows the size of the urinary incontinence treatment devices market worldwide in 2023 and a forecast for 2032.

The Male Urinary Incontinence Market size was valued at USD 6.72 billion in 2023 and is projected to reach USD 10.02 billion by 2032, exhibiting a CAGR of 5.87 % during the forecasts period. Male urinary incontinence is the state where a man leaks urine whenever there is some pressure or there is the need for a control of urine leakage due to reasons such as surgery, aging, or some nervous disorder affecting the muscles that control the bladder. It has social effects as it leads to embarrassment and the feeling of discomfort especially in public places. These include behavior modification, drugs, and as a last resort surgical procedures such as; artificial urinary sphincter or male sling. The 2 applications of treatment are for continence with the hope of regaining bowel control and enhancing the standard of living for clients. Some trends that have been observed in the management of incontinence include evolution in non-surgical approaches to the condition, improvement in people’s consciousness of the condition hence making them seek treatment early, and improvement on features of products used in the management of this condition such as neat enclosures for use by women. The market is prompted through raising population of aged people and enhanced health care thereby enhancing the treatment options.

Urinary Incontinence Market Outlook

The global urinary incontinence market size is expected to grow from USD 12.5 billion in 2023 to approximately USD 19.7 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.2%. This growth is driven by an aging population, increasing prevalence of urinary incontinence, and rising awareness about treatment options. Factors such as advancing healthcare infrastructure, supportive government initiatives, and increased consumer spending on healthcare are also contributing to the market's expansion.

One of the significant growth factors fueling the urinary incontinence market is the growing geriatric population globally. As people age, the likelihood of developing urinary incontinence increases due to factors like weakened pelvic muscles, neurological disorders, and prostate issues in men. With the global population aged 65 and above expected to double by 2050, there is a substantial and growing patient base requiring urinary incontinence management solutions. This demographic shift is expected to propel market growth significantly over the forecast period.

Another critical driver is the increasing prevalence of chronic conditions such as diabetes and obesity, which are known risk factors for urinary incontinence. Diabetes can cause nerve damage that affects bladder control, while obesity increases the pressure on the bladder, leading to leakage. The rising incidence of these conditions is amplifying the need for urinary incontinence products and treatments. Additionally, the lifestyle changes and sedentary habits that are becoming more common in modern society also contribute to the rising prevalence of urinary incontinence.

Technological advancements and innovation in urinary incontinence products are also fostering market growth. Companies are investing heavily in research and development to create more effective, comfortable, and discreet products. Innovations such as advanced catheters, implantable devices, and minimally invasive surgical procedures are improving patients' quality of life and encouraging more individuals to seek treatment. Moreover, the development of smart, connected devices that offer real-time monitoring and management of urinary incontinence is opening new avenues for market expansion.

Regionally, North America holds a significant share of the urinary incontinence market, driven by high healthcare expenditure, advanced healthcare infrastructure, and strong awareness about urinary incontinence management. However, the Asia Pacific region is anticipated to witness the fastest growth during the forecast period. This can be attributed to the increasing geriatric population, rising disposable incomes, and improving healthcare facilities in countries like China and India. Government initiatives aimed at enhancing healthcare services and increasing awareness about urinary incontinence are further supporting market growth in this region.

Urine Incontinence Bags are an essential component in the management of urinary incontinence, particularly for individuals who require continuous drainage due to severe incontinence or mobility issues. These bags are designed to be discreet and comfortable, allowing users to maintain their dignity and independence. With advancements in materials and design, modern urine incontinence bags offer improved leak protection, odor control, and ease of use. They are available in various sizes and styles to suit different needs, including leg bags for daytime use and larger capacity bags for nighttime or extended wear. The growing demand for user-friendly and reliable urine incontinence bags is driving innovation in this segment, with manufacturers focusing on enhancing product features to improve the quality of life for users.

Product Type Analysis

The urinary incontinence market can be segmented by product type into devices, pharmaceuticals, absorbent products, and others. Devices such as catheters, slings, and electrical stimulators are gaining popularity due to their effectiveness in managing urinary incontinence. Catheters, in particular, are widely used and are expected to continue dominating the market due to their critical role in managing severe cases of incontinence. The development of more user-friendly and advanced catheter designs is also contributing to their growing adoption.

Pharmaceuticals constitute another significant segment in the urinary incontinence market. Medications such as an

The global urinary incontinence products market, valued at $14.59 billion in 2025, is projected to experience robust growth, driven by a rising geriatric population, increasing prevalence of incontinence, and advancements in product technology. The market's compound annual growth rate (CAGR) of 9.2% from 2025 to 2033 indicates significant expansion opportunities. Key segments driving this growth include hospital applications, where the demand for high-absorbency products remains substantial, and the homecare segment, which is experiencing considerable growth fueled by the preference for at-home care and aging-in-place trends. Urine absorbents currently dominate the product type segment, but there's increasing demand for more advanced products like incontinence bags offering enhanced comfort and discretion. This shift reflects evolving consumer preferences and a push towards improved quality of life for individuals with incontinence. Geographic variations exist, with North America and Europe currently holding substantial market share due to higher healthcare spending and awareness. However, Asia-Pacific is expected to witness significant growth over the forecast period driven by factors like increasing disposable incomes and expanding healthcare infrastructure. Competitive landscape analysis reveals the presence of established players like Kimberly-Clark and Procter & Gamble, alongside several regional manufacturers. Market competition is fierce, emphasizing innovation, product differentiation, and strategic partnerships to maintain market share. The increasing awareness of urinary incontinence and its management is crucial to the market's expansion. Improved access to healthcare, particularly in developing regions, will further propel market growth. While factors such as high product costs and potential side effects of some products might pose some challenges, the overall positive trajectory is largely driven by unmet needs, technological advancements that improve product efficacy and comfort, and the growing elderly population worldwide. Continued research into more effective and discreet products, particularly those addressing specific incontinence types, is expected to further fuel market growth in the coming years. Companies are investing in developing sustainable and eco-friendly options to respond to evolving consumer concerns regarding environmental impact.

The global urinary incontinence devices market is experiencing robust growth, driven by an aging population, increasing prevalence of urinary incontinence, rising healthcare expenditure, and technological advancements leading to more effective and comfortable treatment options. The market's size in 2025 is estimated at $7 billion, reflecting a steady increase from previous years. A Compound Annual Growth Rate (CAGR) of 5% is projected for the period 2025-2033, indicating sustained market expansion. Key drivers include the development of minimally invasive procedures, improved device designs offering greater patient comfort and efficacy, and the growing awareness of available treatment options. Furthermore, the increasing availability of reimbursement options and supportive government initiatives are fueling market growth. Market segmentation reveals a strong presence of key players such as Boston Scientific Corporation, Johnson & Johnson, C. R. Bard, and Coloplast Group, competing through innovation and strategic acquisitions. While the market faces challenges such as high device costs and potential side effects associated with certain treatments, these are being countered by ongoing research and development focused on enhancing safety and efficacy. Regional variations in market penetration are expected, with North America and Europe maintaining a significant market share due to advanced healthcare infrastructure and higher awareness. However, developing economies are showing promising growth potential as healthcare systems improve and disposable incomes rise. The forecast period (2025-2033) anticipates continued growth, driven by the factors outlined above, creating substantial opportunities for established players and new entrants alike.

Check out Market Research Intellect's Female Stress Urinary Incontinence Treatment Devices Market Report, valued at USD 4.5 billion in 2024, with a projected growth to USD 7.2 billion by 2033 at a CAGR of 6.9% (2026-2033).

Global Urinary Incontinence market size is expected to reach $17.39 billion by 2029 at 6.8%, segmented as by urge incontinence, overactive bladder, urinary urgency

Learn more about Market Research Intellect's Bladder Control Products For Urinary Incontinence Market Report, valued at USD 4.5 billion in 2024, and set to grow to USD 7.2 billion by 2033 with a CAGR of 6.9% (2026-2033).

The global market for female urinary incontinence (FUI) products is experiencing robust growth, driven by an aging population, increasing awareness of FUI, and advancements in product technology. While precise market size figures for 2025 are unavailable, based on industry reports and considering a typical market size for similar healthcare products, we can estimate a 2025 market value of approximately $8 billion USD. This market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 5-7% from 2025 to 2033, indicating a substantial expansion. Key drivers include the rising prevalence of FUI among women, particularly post-menopause and postpartum, coupled with improved access to healthcare and increased disposable incomes in developing economies. Further growth is fueled by technological advancements leading to more absorbent, comfortable, and discreet products, along with rising awareness campaigns and improved healthcare infrastructure. The market is segmented by product type (stress incontinence, urge incontinence, mixed incontinence) and application (hospitals, ambulatory surgery centers, gynecology clinics, home healthcare, etc.), with absorbent pads and adult diapers comprising the largest segments. While pricing pressures and the availability of alternative treatments represent potential restraints, the overall market outlook for FUI products remains positive, driven by the underlying demographic and healthcare trends. The key players in this competitive market include established multinational corporations such as Kimberly-Clark, Procter & Gamble, and SCA, as well as several specialized medical device companies. These companies are actively engaged in product innovation, strategic partnerships, and geographic expansion to capture market share. Regional variations in market growth are expected, with North America and Europe currently leading the market due to high healthcare spending and awareness. However, significant growth potential exists in Asia-Pacific and other emerging markets as healthcare infrastructure improves and disposable incomes rise. The continuous improvement of product technology, coupled with rising awareness and increasing healthcare accessibility, positions the FUI products market for sustained growth in the coming years.

The External Urine Management Products Market Size Was Valued at USD 16.95 Billion In 2022 And Is Expected to Grow at A CAGR Of 8.41 % During the Forecast Period, Reaching USD 30.96 Billion The increasing prevalence of urological problems and the development of sophisticated urinary incontinence devices are key factors expected to drive the growth of the external urine management products market. In addition, rising government spending and numerous organizations’ awareness campaigns other factors expected to drive the growth of the target market. However, the absence of awareness about recent advances in urinary incontinence devices may hamper the growth of the external urine management products market. Furthermore, the increasing prevalence of chronic conditions in geriatric patients, such as peripheral arterial disease, pulmonary embolism, and urinary tract infection create growth opportunities for the target market. External urine management products are mainly used to collect urine in both men and women who have urinary incontinence. A broken sphincter and a malfunctioning bladder are the most common cause of male urinary incontinence. External urine management products assist in the collection and retention of urine and the effective management of urinary incontinence, which causes uncontrollable urine leakage.

The global Urinary Incontinence Devices Market is expected to rise $11,904.23 million by 2034 And anticipated to grow at a CAGR of 11.0%.

The global urinary incontinence products market is experiencing robust growth, projected to reach a substantial size of $13.65 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2019 to 2033. This significant expansion is driven by several key factors. The aging global population, a primary contributor to urinary incontinence, is a major driver. Increased awareness of available treatment options, coupled with improved product efficacy and convenience, is encouraging higher adoption rates. Technological advancements, such as the development of absorbent and comfortable products, are further fueling market growth. Furthermore, rising healthcare expenditures and improved access to healthcare services in developing economies contribute to the market's expansion. The market is segmented based on product type (adult diapers, pads, briefs, etc.), end-user (hospitals, nursing homes, home care), and distribution channels (retail pharmacies, online sales). Major players, including Kimberly-Clark, SCA, Unicharm, Procter & Gamble, and several others listed, compete intensely in this market, constantly striving for innovation and market share. The market's future trajectory will depend on continued technological advancements, the evolution of healthcare policies and reimbursement models, and changes in consumer preferences. Factors such as fluctuations in raw material costs and the potential for increased regulation could pose challenges to market growth. However, overall market trends indicate continued robust expansion driven by population demographics and the increasing prevalence of urinary incontinence. Further market segmentation analysis (though unavailable in the provided data) would refine the understanding of specific growth areas.